uPA | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,715 results for “uPA”

Upamostat Plus Gemcitabine Shows Tolerability in Advanced Pancreatic Cancer Phase I Trial

Biotron's BIT-HBV001 Shows Superior Antiviral Activity Against Hepatitis B Compared to Standard Therapy

Urinary MMP-1 Identified as Potential Biomarker for Calcium Oxalate Kidney Stone Disease

Hemab Therapeutics Unveils HMB-002 Proof-of-Mechanism Data in VWD and Announces Novel Antifibrinolytic HMB-003 at ISTH 2026

Upadacitinib Outperforms Dupilumab in Landmark LEVEL UP Trial for Moderate-to-Severe Atopic Dermatitis

Monopar Therapeutics Initiates Phase 1a Trial of uPAR-Targeted Radiopharmaceutical MNPR-101-Lu in Advanced Cancers

AbbVie's RINVOQ Receives Positive CHMP Opinion for Giant Cell Arteritis Treatment

Six-Year Upadacitinib Safety Data Shows Comparable Cardiovascular Risk in Atopic Dermatitis Patients

Delhi High Court Orders CDSCO to Review Safety of GLP-1 Diabetes Drugs Used for Weight Loss

Upadacitinib 30mg Demonstrates Superior Efficacy Among JAK Inhibitors for Atopic Dermatitis, While Safety Analysis Reveals New Infection Risks

Page 1 of 50